Shanghai RAAS Blood Products Co., Ltd.
002252
Pozycja w akcjach
#3637
Shanghai RAAS Blood Products Co., Ltd. engages in the research, development,... Shanghai RAAS Blood Products Co., Ltd. engages in the research, development, production, and sale of blood products. It provides human albumin, intravenous injection of human immunoglobulin, coagulation factor products, vaccines, diagnostic reagents, and testing services. The company was founded by Kieu Hoang on October 29, 1988 and is headquartered in Shanghai, China.
Cena akcji
$0.70717976
Kapitalizacja rynkowa
$4.66B
Zmiana (1 dzień)
-0.20%
Zmiana (1 rok)
-24.51%
Kraj
CN
Handel Shanghai RAAS Blood Products Co., Ltd. (002252)
Kategoria
Healthcare
EPS dla Shanghai RAAS Blood Products Co., Ltd. (002252)
EPS na dzień June 2026 TTM: $0.03
Według najnowszych raportów finansowych i ceny akcji firmy Shanghai RAAS Blood Products Co., Ltd., obecny EPS (TTM) wynosi $0.03. Na koniec roku 2023 firma miała EPS w wysokości $0.04, równa się do EPS z roku 2022, który wynosił $0.04.
Historia EPS dla Shanghai RAAS Blood Products Co., Ltd. od 2005 do 2026
EPS na koniec każdego roku
| Rok | EPS | Zmień |
|---|---|---|
| 2026 (TTM) | $0.03 | -47.80% |
| 2024 | $0.05 | 18.64% |
| 2023 | $0.04 | -6.16% |
| 2022 | $0.04 | 34.44% |
| 2021 | $0.03 | 0.33% |
| 2020 | $0.03 | 75.00% |
| 2019 | $0.02 | -138.14% |
| 2018 | $-0.05 | -272.80% |
| 2017 | $0.03 | -45.05% |
| 2016 | $0.05 | 6.26% |
| 2015 | $0.04 | 130.41% |
| 2014 | $0.02 | 203.13% |
| 2013 | $0.01 | -37.25% |
| 2012 | $0.01 | 12.09% |
| 2011 | $0.01 | 13.75% |
| 2010 | $0.01 | 40.35% |
| 2009 | $0.01 | 14.00% |
| 2008 | $0.01 | 19.05% |
| 2007 | 0.00 | -38.24% |
| 2006 | $0.01 | 3.03% |
| 2005 | $0.01 | 0.00% |
EPS dla podobnych firm lub konkurentów
| Firma | EPS | Różnica w EPS | Kraj |
|---|---|---|---|
| $17.32 | 66,260.15% |
US
|
|
| $-7.98 | -30,674.71% |
US
|
|
| $-5.29 | -20,368.20% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | 106,183.52% |
NL
|
